Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
Rev Bras Parasitol Vet ; 33(3): e003324, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39140496

RESUMEN

Cyathostomins are the largest group of parasites in horses that can be controlled by ivermectin (IVM). This study aimed to run a four-dose titration trial of IVM in 28 naturally infected Thoroughbred yearlings. The local Strongyle population had been recorded to be resistant to IVM (200 µg/kg). The parasite fecal egg count (FEC) was performed to investigate the egg reappearance period (ERP) of two and five weeks (w2pt and w5pt) after IVM treatment. FEC was > 1000 on day zero for all groups. Although 100% FEC reduction was reported at w2pt for all concentrations, the FEC at w5pt revealed < 83% efficacy. This study reports the reduction of ERP using the label dose as well as 300, and 400 µg/kg (double dose) of IVM. The protocol allowed IVM to significantly suppress FEC w2pt although not eliminating adult worms, failing to guarantee an extension of its protection period over 8 weeks. Moreover, the FEC at w5pt possibly means the infection was not cleared, and worms reestablished egg laying. We raised the possibility of withdrawing IVM of control programs when the drug has less than 80% FEC reduction at w5pt.


Asunto(s)
Ivermectina , Recuento de Huevos de Parásitos , Animales , Ivermectina/uso terapéutico , Ivermectina/administración & dosificación , Caballos/parasitología , Brasil , Enfermedades de los Caballos/parasitología , Enfermedades de los Caballos/tratamiento farmacológico , Enfermedades de los Caballos/diagnóstico , Femenino , Antiparasitarios/uso terapéutico , Antiparasitarios/administración & dosificación , Infecciones Equinas por Strongyloidea/tratamiento farmacológico , Infecciones Equinas por Strongyloidea/parasitología , Infecciones Equinas por Strongyloidea/diagnóstico , Heces/parasitología
2.
Parasitology ; : 1-5, 2022 Feb 16.
Artículo en Inglés | MEDLINE | ID: mdl-35241201

RESUMEN

Gastrointestinal parasite control has been a major challenge to livestock due to the failure of anthelmintic treatments. Monepantel (MNT) was introduced in 2009 as an alternative treatment option showing a new mechanism of action against nematode parasites. To study the response of MNT in a suppressive regime, 45-Suffolk and White Dorper naturally infected sheep were divided into one of three groups, G1: control ­ with no treatment, G2: MNT at 2.5 mg kg−1 live weight (LW) PO every 30 days, and G3: MNT at 4.0 mg kgLW−1 PO every 30 days for 6 months. Every 15 days, the animals were individually weighed (body weight, BW) and checked for Famacha (FMC) and body condition score (BCS). The efficacy of MNT was evaluated weekly by fecal egg count (FEC) every month. FEC showed >97% efficacy at the start of the experiment, revealing a significant reduction for G2 (28%) and G3 (39%) in the following months. There was no treatment, BW or BCS effect between treatments; however, there was a period (P < 0.0001) and a treatment vs period interaction (P < 0.0001) for BW. The data revealed that MNT at a therapeutic and suppressive dose had a non-linear polynomial efficacy regression (R2) of 0.988 and 0.992, respectively. This original experiment demonstrates how short-interval and suppressive MNT treatments would rapidly select Haemonchus contortus, showing a fast susceptible-resistance phenotypic population replacement. Therefore, it is suggested that MNT might be carefully used in parasite control programmes alongside other management strategies (i.e. FMC, BCS) to reduce treatment frequency and the selection process for resistance.

3.
Arq. Inst. Biol ; 85: e0972018, 2018. ilus, tab
Artículo en Inglés | LILACS, VETINDEX | ID: biblio-999165

RESUMEN

Evaluation of alveolar macrophage functions of cattle is an important tool in order to assess whether measures taken during the cattle husbandry can decrease the respiratory tract defense. The aim of this study was to determine whether dexamethasone used at therapeutic dose can affect the oxidative metabolism of alveolar macrophages of cattle. This was evaluated by two tests, the fluorometric and colorimetric. The similarity of the results was studied, using alveolar macrophages of six healthy cattle, obtained from bronchoalveolar lavage on a basal and an immunosuppressant moment after the application of dexamethasone. For the fluorometric test, alveolar macrophages were incubated with Staphylococcus aureus and 2'-7'dichlorohidroflurescein, and analyzed by flow cytometer. For the colorimetric test, alveolar macrophages were incubated with Phorbol 12- miristate-13 acetate and nitroblue tetrazolium, dissolved and analyzed in a spectrophotometer. It was noted that dexamethasone therapeutic dose (0.05 mg/kg) reduced the functions of alveolar macrophages from healthy bovine. This result was observed by both tests with the difference that the flow cytometry assay was more informative for identifying which specific cellular function has been compromised.(AU)


A avaliação das funções de macrófagos alveolares de bovinos é uma ferramenta importante no intuito de analisar se medidas adotadas durante a criação desses animais diminuem a defesa do trato respiratório, aumentando a susceptibilidade à pneumonia. O objetivo deste trabalho foi verificar se a dexametasona em dose terapêutica afeta o metabolismo oxidativo de macrófagos alveolares de bovinos por meio de duas provas, a fluorimétrica e a colorimétrica, avaliando a similaridade dos resultados. Para tanto, utilizaram-se macrófagos alveolares de seis bovinos sadios, obtidos por meio de lavados broncoalveolares em um momento basal e em um momento imunossupressor, após a aplicação da dexametasona. Na prova fluorimétrica, os macrófagos alveolares foram incubados com Staphylococcus aureus e o fluorófilo 2'-7' diclorohidrofluresceína e analisados por citometria de fluxo. Na prova colorimétrica, os macrófagos alveolares foram incubados com Phorbol 12- miristate-13 acetate e nitroazul de tetrazolium, dissolvidos e analisados em espectofotômetro. Observou-se que a dexametasona em dose terapêutica (0,05 mg/kg) reduziu as funções dos macrófagos alveolares de bovinos sadios, sendo este resultado obtido em ambas as provas, com a diferença de que o teste de citometria de fluxo foi mais esclarecedor por identificar qual função celular específica foi comprometida.(AU)


Asunto(s)
Animales , Bovinos , Sistema Respiratorio , Macrófagos Alveolares , Neumonía , Staphylococcus aureus , Dexametasona
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA